Top compounds associated with response to TIMM17B


Feature Type Standardized
Nominal ANOVA
mRNA brivanib CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.14 5e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 6e-05
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 8e-05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.2 0.0002
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA pluripotin CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA PD-0325901 CCLE pan-cancer AAC -0.16 0.0002
Download CSV